A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country

BMC Public Health

Table 2 Summary data of collected samples, their sources, strengths and dosage forms

Medicine’s name, dosage, dose form	Sampling area		Pharmacy entity			Sample source
Medicine’s name, dosage, dose form	Urban	Rural	Wholesaler	Community pharmacy	RDF	Local	Import
Acetaminophen, 500 mg/tab	88	30	43	66	9	118	0
Acetylsalicylic acid, 81 mg/tab	88	30	43	66	9	108	10
Amlodipine, 10 mg/tab	88	30	43	66	9	49	69
Amoxicillin, 500 mg/tab	88	30	43	66	9	45	73
Cefotaxime, 1 g/vial	88	30	43	66	9	14	104
Cetirizine, 10 mg/tab	88	30	43	66	9	9	109
Ciprofloxacin, 500 mg/tab	88	30	43	66	9	14	104
Citramon-P (Acetylsalicylic acid+acetaminophen+caffeine), 450 mg /tab	88	30	43	66	9	102	16
Diclofenac sodium, 100 mg/tab	88	30	43	66	9	73	45
Ibuprofen, 400 mg/tab	88	30	43	66	9	3	115
Metronidazole, 0.5%/100 ml/infusion	88	30	43	66	9	14	104
Nystatin, 5,000,000 IU/tab	88	30	43	66	9	0	118
Omeprazole, 20 mg/tab	88	30	43	66	9	0	118
Panangin (Aspartic Acid, L- potassium and magnesium), 298 mg/tab	88	30	43	66	9	0	118
Sildenafil citrate, 100 mg/tab	88	30	43	66	9	16	102
Total (N = 1770)	1320	450	645	990	135	565	1205

ISSN: 1471-2458